Management of epilepsy in patients with Rett syndrome: perspectives and considerations

Area of Science:

• Neuroscience
• Genetics
• Pediatrics

Background:

• Rett syndrome (RTT) is a common neurodevelopmental disorder.
• Epilepsy affects the majority of RTT patients, with about one-third experiencing drug-resistant epilepsy.
• Mutations in the methyl-CpG-binding protein 2 (MECP2) gene are linked to RTT and epilepsy, particularly drug-resistant forms.

Purpose of the Study:

• To review the clinical and electrophysiological aspects of epilepsy in Rett syndrome.
• To discuss the current treatment approaches for epilepsy in RTT patients.

Main Methods:

• This is a review article.
• It synthesizes existing literature on epilepsy in RTT, including clinical manifestations, electroencephalographic findings, and treatment outcomes.

Main Results:

• Seizures are a common feature of RTT, often appearing at a specific clinical stage.
• While electroencephalographic abnormalities are well-documented, detailed information on seizure semiology and antiepileptic drug effectiveness is less understood.
• Drug-resistant epilepsy is a significant challenge in approximately one-third of RTT cases.

Conclusions:

• Epilepsy is a critical comorbidity in Rett syndrome, necessitating further research into its specific characteristics and optimal management strategies.
• Understanding seizure semiology and evaluating the efficacy of various antiepileptic drugs are crucial for improving patient care in RTT.